Duodenal disorder

Summary

Duodenal disorder (MONDO:0002866) is a disease (an umbrella term covering 6 Mondo subtypes) and 1 clinical trial. A subtype of small intestine disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Umbrella term: 6 Mondo subtypes
• Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	duodenal disorder
Mondo ID	MONDO:0002866
MeSH	D004378
DOID	DOID:4072
ICD-11	1195691020
SNOMED CT	52182008
UMLS	C0013289
MedGen	8502
Anatomy (UBERON)	UBERON:0002114
Is cancer (heuristic)	no

Also known as: disease of duodenum · disease or disorder of duodenum · disorder of duodenum · duodenum disease · duodenum disease or disorder

Disease family

An umbrella term covering 6 Mondo subtypes.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › intestinal disorder › small intestine disorder › duodenal disorder

Related subtypes (9): small intestine diverticulitis, small intestine neoplasm, celiac disease, pouchitis, atresia of small intestine, congenital short bowel syndrome, enteritis, small intestinal bacterial overgrowth, small intestine duplication

Subtypes (6): duodenal obstruction, duodenitis, duodenal ulcer, biliary dyskinesia, duodenogastric reflux, tumor of duodenum

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT06333093	Not specified	COMPLETED	Duodenal tIssue ResEction aCquisiTion (DIRECT) Study